At Veeda Lifesciences, we offer an extensive portfolio of validated bioanalytical assays to support Generics, NCEs, and Biotherapeutics across various platforms like LC/MS/MS. From pharmacokinetics (PK) to immunogenicity and biomarker analysis, our assays deliver reliable, high-quality data for every phase of drug development. Explore the complete list here: https://bit.ly/4hT9YPt To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com. Excellence in Everything #Bioanalysis #DrugDevelopment #Pharmacokinetics #ClinicalResearch #AssayValidation #Biotherapeutics #VeedaBiopharma
Veeda Lifesciences
Research Services
Ahmedabad, Gujarat 72,948 followers
Integrated, Tech-Driven, Global CRO
About us
We partner with innovator and generic companies using our high-quality infrastructure and a global network of clinical trial sites, to launch novel therapies and new products for patients worldwide. Building on our strong foundation in global oncology studies, we offer solutions across multiple therapeutic domains, accelerating pipelines through AI and advanced real-world data capabilities. As an Integrated, Tech-driven & Global CRO we support the development of biotherapeutics and small molecules by blending scientific expertise with advanced technology. With offices in 9 countries and sites spanning across 26 geographies, we offer global reach and local expertise. Our integrated service model spans the entire drug development lifecycle, offering expertise in: 1. Preclinical studies 2. BA/BE Studies 3. Early Phase clinical trials 4. Late-phase clinical trials 5. Bioanalytical services 6. Biopharma solutions
- Website
-
https://veedalifesciences.com/
External link for Veeda Lifesciences
- Industry
- Research Services
- Company size
- 501-1,000 employees
- Headquarters
- Ahmedabad, Gujarat
- Type
- Privately Held
- Founded
- 2004
- Specialties
- BA/BE Studies, Central Bioanalytical Services, First-in-Man Studies , Biosimilars , Clinical Data Management, Phase 2 trials, Phase 3 Trials, biologics, biostatistics, early phase trials, pharmacovigilance, late phase trials, preclinical research & development, and Phase 1 trials
Locations
Employees at Veeda Lifesciences
Updates
-
Every breakthrough drug starts as a complex molecular blueprint—one that must be meticulously understood, tested, and refined before it reaches patients. But the journey from discovery to approval is filled with challenges: structural variations, stability concerns, and regulatory hurdles. At Veeda Lifesciences, we go beyond routine analysis. As Experts in Analytical Sciences, we transform raw data into actionable insights, accelerating drug development with precision-driven CMC analytical services. Imagine developing a promising biotherapeutic. You need to confirm its primary structure, ensure its higher-order stability, and characterize its molecular profile, all while meeting regulatory expectations. Our state-of-the-art techniques provide: • High-Resolution Mass Spectrometry (HRMS) and Liquid Chromatography for in-depth protein analysis • Advanced biophysical methods to evaluate stability and integrity • Rapid N-Glycan Analysis in just 3–4 days, cutting down processing time from weeks to days With expert scientists, cutting-edge infrastructure, and regulatory-ready data, Veeda Lifesciences helps you navigate the complexities of biopharmaceutical development with confidence. Learn more about our capabilities: https://bit.ly/4lbQBDt To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com. Excellence in Everything #AnalyticalSciences #CMCAnalytics #Biopharma #StructuralCharacterization #VeedaLifesciences #Biologics #Veeda
-
-
As an intravenous iron replacement therapy, Ferric carboxymaltose supports the treatment of iron deficiency in anemia, especially for those who cannot tolerate or respond to oral supplements. The USFDA had recently introduced bioequivalence study guidelines & Veeda Lifesciences is stepping up to lead the charge by offering full-spectrum, regulatory-aligned study solutions for both adult patients and healthy subject. With a high success rate and a strong portfolio of meticulously designed studies, our scientific leadership team is committed to optimizing drug development processes while ensuring patient safety and data accuracy on a global scale. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #FerricCarboxymaltose #DrugDevelopment #BioequivalenceStudy #Veeda #VeedaLifesciences #ClinicalTrials
-
🎉 Celebrating Success at Veeda Lifesciences! 🎉 We are happy to announce that the third cohort of Veeda’s flagship Management Development Program, V-NAYAC (Veeda Nurturing Accountability and Capability), has successfully completed the 6-month program! 🌟 Participants were awarded certificates by our Group CEO and MD, Dr. Mahesh Bhalgat, alongside Ms. Amee Kanuga, Head (QA), and Mr. Manmohansinh Chauhan, Interim CHRO. During the ceremony, participants shared their experiences and highlighted key learnings in areas such as Planning & Goal Setting, Managerial Communication, Team Development, Emotional Intelligence, Solution Centricity, Time Management, and fostering a Culture of Accountability. The current cohort of participants of the V-NAYAC program featured employees across different site locations in Ahmedabad (Gujarat) including Clinical Research, Clinical Operations, Bioanalytical Research, Quality Assurance, Biopharmaceutics and Project Management, Administration and Maintenance and Training and Development. The program saw enthusiastic participation and engagement from Veeda employees, who benefited from mentorship and coaching sessions led by management experts Ms. Hiral Matalia( she / her) and Ms. Pooja Dhruv. The interactive learning modules provided invaluable insights and growth opportunities. Congratulations to all participants for their dedication and achievements! 🎓👏 #VeedaLifesciences #VNAYAC #LeadershipDevelopment #EmployeeGrowth #TeamVeeda BHOIRA AKIL Archana Gosai arpit Christian BHARGAVKUMAR DAVE Darshil Patel Devendra Chaudhari Dhiren Dodiya Ekta Bharvada Dr. Foram Patel Haresh Diyora Hetna Pandya Jaimin Vaishnav Ketan Dobariya Keyur Prajapati Kinjal Kansara Kishor Gohil Krishnakant Patel Manoj Chaudhari Mihir Patel Mittal oza Kikani Nilesh Ravichandra Patel Ronak Shah Shaikh Jabir Husen Dr Sumit Devaliya Princy Khandelwal Arjun Vithlani
-
-
-
-
-
+15
-
-
March is Multiple Myeloma Awareness Month—a time to amplify our efforts in raising awareness and supporting those affected by this challenging condition. At Veeda Lifesciences , we remain dedicated to advancing research, expanding access to innovative treatments, and driving better outcomes for patients. Let’s continue working towards a future of improved care and hope for the Myeloma community. To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #MultipleMyelomaAwarenessMonth #MultipleMyeloma #CancerAwareness #BloodCancer #AwarenessMonth #Treatment #Veeda #VeedaLifesciences
-
-
Insulin Aspart has emerged as one of the promising therapies for both type 1 and type 2 diabetes. Its rapid-acting properties has become an effective management tool by improving glycemic control, ensuring better and faster blood sugar regulation. In a recent article published in Clinical Pharmacology in Drug Development, Veeda Expert Dr. Hiren Mehta co-authored a study demonstrating how Insulin Aspart achieves faster subcutaneous absorption compared to regular insulin, paving the way for enhanced biosimilarity and improved patient outcomes. - Title: Equivalence of Biosimilarity in Pharmacokinetic and Pharmacodynamic Properties of Recombinant Human Insulin Aspart - Authors: Sneha A. Dongre, Gauri A. Kulkarni, Damodar Thapa, Nikhil Ghade, Jeseena Lona, Hiren Prajapati, Hiren Mehta, Swati Guttikar, Archana R. Krishnan, Sanjay M. Sonar Read the Article Now: https://bit.ly/4kEtilr To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #Veeda #VeedaLifesciences #DrugDevelopment #ScientificArticle #ClinicalAffairs #Biosimilarity
-
-
𝐌𝐞𝐞𝐭 𝐕𝐞𝐞𝐝𝐚 𝐋𝐢𝐟𝐞𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐚𝐭 𝐒𝐰𝐢𝐬𝐬 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐃𝐚𝐲 2025 We are excited to be a part of Swiss Biotech Day 2025, one of Europe’s leading biotechnology conferences, on May 5-6, 2025, at Congress Centre Basel, Switzerland. At Veeda Lifesciences, we combine end-to-end clinical trial services with advanced technology to support (Bio)Pharma in bringing new therapies to market. Here’s how we’re making a difference: One-Stop CRO Solutions: Comprehensive services under one roof, covering preclinical research, early and late-phase trials, bioanalytical research, and pharmacovigilance. Full-Service Capabilities: From study design and patient recruitment to site management, data management, and regulatory support, ensuring seamless trial execution. Biopharma Expertise: Specialized bioanalysis and analytical sciences for biotherapeutics, delivering precise PK, PD, immunogenicity, and biomarker insights to advance biologics and biosimilars. Tech-Powered Efficiency: AI-driven recruitment, real-world data integration, and advanced clinical trial management systems to optimize processes and reduce timelines. Let’s Connect! Meet André Bongartz, Director of Business Development, to explore how Veeda can support your clinical research goals. Schedule a Meeting Here: https://bit.ly/4gCPpFH To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #SwissBiotechDay #ClinicalTrials #Biopharma #DrugDevelopment #ClinicalBioanalysis #VeedaLifesciences
-
-
DCAT Week is here, and our excitement is off the charts! Our team has touched down in New York and can’t wait to meet our esteemed partners, welcome new collaborators, and reconnect with cherished friends. Let’s talk about how our deep expertise, strategic study designs, and robust infrastructure can maximize your first-to-market potential —schedule a meeting with us now - https://bit.ly/4gCPpFH Mahesh Bhalgat Melissa Peloquin DCAT (Drug, Chemical & Associated Technologies Association) To learn more about us, visit www.veedalifesciences.com or reach out at info@veedalifesciences.com Excellence in Everything #DCATWeek #Veeda #DCATWeek2025 #VeedaLifesciences #biotherapeutics #generics
-
-
🌟 Veeda Lifesciences GCP Training Success! 🌟 We are happy to share that over 820 employees at our Ahmedabad and Mehsana locations have successfully completed the mandatory regulatory training on Good Clinical Practices (GCP). This comprehensive 3-day training was conducted by the esteemed Dr. Mira Desai, Former Professor & Head of Pharmacology at B.J. Medical College, Ahmedabad, and CDSCO-appointed expert for inspection & training of clinical research facilities. The training focused on: ICH Harmonized Guideline for GCP E6 (R3) New Drugs and Clinical Trial Rules 2019 and its amendments Use of digital technology in clinical trials Our in-house training team also led insightful sessions on good clinical and good documentation practices, followed by an engaging open forum discussion. Catch a glimpse of the training program conducted for Veeda employees at Ahmedabad and Mehsana! #VeedaLifesciences #GCPTraining #ClinicalResearch #GoodClinicalPractices #DigitalHealth #ClinicalTrials #EmployeeDevelopment #Pharmacology #HealthcareInnovation #Ahmedabad #Mehsana Amee Kanuga Pranav Dalal Manmohansinh Chauhan Dr. Tulsi Das Mishra Dr. Jatin Vadhvana Devangi Dave Rachana Shah Dr. Vinita Verma Kinjal Kansara HARDIK PATEL Manish Dutt Ravindrasinh Gadhavi Dipen Barot Gaurav Kudpane
-
-
-
-
-
+15
-
-
May the colors of Holi brighten your life and bring good health, happiness and prosperity. We wish you all a Happy Holi! #Veeda #VeedaLifesciences #Holi #HappyHoli #Holi2025 #FestivalOfColors
-